Ptosis evaluation and management in the 21st century

M A Iwamoto1

  • 1Division of Ophthalmology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.

Insights

Proper ptosis diagnosis involves evaluating specific signs and symptoms to guide management. New technologies offer promising future treatments for eyelid ptosis, but indications and outcomes remain key considerations.

Area of Science:

  • Ophthalmology
  • Neurology
  • Genetics

Background:

  • Ptosis, or drooping eyelid, diagnosis and management require a systematic clinical evaluation.
  • Associated findings like motility deficits, pupillary abnormalities, and systemic symptoms are crucial for diagnosis.
  • Understanding levator function is key to assessing the severity and potential surgical outcomes for ptosis.

Purpose of the Study:

  • To outline a directed evaluation for determining the etiology and management of ptosis.
  • To discuss the clinical significance of concomitant findings in ptosis assessment.
  • To review current and future management options for ptosis correction.

Main Methods:

  • Clinical evaluation focusing on specific signs and symptoms of ptosis.
  • Assessment of ocular motility, pupillary function, and levator muscle function.
  • Review of existing literature and emerging technologies for ptosis management.

Main Results:

  • The evaluation of specific clinical signs and symptoms is essential for accurate ptosis diagnosis.
  • Associated ocular and systemic findings significantly impact management decisions.
  • Current management options are reviewed, with a focus on indications and outcomes.

Conclusions:

  • A thorough clinical evaluation is fundamental for appropriate ptosis management.
  • Emerging technologies like CO2 laser and advancements in molecular biology hold potential for novel ptosis therapies.
  • The core principles of indications and outcomes remain paramount in ptosis treatment, regardless of technological advancements.